Search

everythinglearnresearchcommunity

for

Search:↓

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

Androgens can both increase body hair and cause scalp hair loss.

Clascoterone may be an effective topical treatment for hair loss.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Long-term anabolic steroid use can lead to heart and metabolic health issues.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Olive Mill Wastewater extract could potentially improve hair growth and prevent hair loss.

Mouse genital development depends on male or female hormones for specific features.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.